Saturday, September 04, 2021 9:44:31 PM
ERYTECH TO PARTICIPATE IN THE CITI 16TH ANNUAL BIOPHARMA CONFERENCE
(September 8 2021 through September 10, 2021)
ERYTECH HOSTING KEY OPINION LEADER WEBINAR ON ERYASPASE IN PANCREATIC CANCER
ERYTECH Hosting Key Opinion Leader Webinar on Eryaspase in Pancreatic Cancer
(September 1 2021)
ERYTECH GRANTED U.S. FDA FAST TRACK DESIGNATION FOR ERYASPASE IN HYPERSENSITIVE ALL
(July 29, 2021)
Erytech is starting the push for sales, fda approval by the end of the month if not sooner. After fda approval eryteck will hit the ceiling.
Recent ERYP News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/30/2023 03:33:12 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/29/2023 07:52:47 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/28/2023 12:53:59 PM
- Micro Cap Bid Up Right Before Opening Bell • AllPennyStocks.com • 05/09/2023 02:30:00 PM
FEATURED Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • Apr 22, 2024 8:49 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM